ORIGINAL ARTICLE TREATMENT AND FOLLOW-UP OF ORAL DYSPLASIA A SYSTEMATIC REVIEW AND META-ANALYSIS

Size: px
Start display at page:

Download "ORIGINAL ARTICLE TREATMENT AND FOLLOW-UP OF ORAL DYSPLASIA A SYSTEMATIC REVIEW AND META-ANALYSIS"

Transcription

1 ORIGINAL ARTICLE TREATMENT AND FOLLOW-UP OF ORAL DYSPLASIA A SYSTEMATIC REVIEW AND META-ANALYSIS Hisham M. Mehanna, MBChB, FRCS, 1 Tim Rattay, MBChB, MRCS, 1 Joel Smith, MBChB, MRCS, 1 Christopher C. McConkey, MSc 2 1 Department of Head and Neck Surgery, Institute of Head and Neck Studies and Education, Department of Head and Neck Surgery, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom. hisham.mehanna@uhcw.nhs.uk 2 Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, United Kingdom Accepted 18 February 2009 Published online 19 May 2009 in Wiley InterScience ( DOI: /hed Abstract: Background. The aim of this study was to inform an evidence-based management policy for oral dysplastic lesions. Methods. Systematic review was performed with metaanalysis. Studies reporting follow-up of patients with histologically confirmed oral dysplasia were included. Outcome measures included malignant transformation rate (MTR) and time to malignant transformation (TMT). Subgroup analysis was performed by histologic grade, clinical risk factors, and treatment modality. Heterogeneity was assessed. Results. Fourteen nonrandomized studies, reporting on 992 patients, were included. There was considerable heterogeneity between studies: mean overall MTR ¼ 12.1% (confidence interval: 8.1%, 17.9%) and mean TMT ¼ 4.3 years. Histologic grade significantly affected mean MTR (p <.008). Lesions that were not excised demonstrated considerably higher MTR than those that were excised (p ¼.003). Conclusions. Oral dysplasia showed a significant rate of transformation to cancer, which was related to grade and was decreased significantly but not eliminated by excision. Correspondence to: H. M. Mehanna This study was presented at the American Head & Neck Society Annual Meeting, San Francisco, USA, July 23, 2008, and British Association of Head and Neck Oncologists Annual Meeting, London, United Kingdom, April 25, 2008 (poster). VC 2009 Wiley Periodicals, Inc. This suggested the need for excision and continued surveillance. VC 2009 Wiley Periodicals, Inc. Head Neck 31: , 2009 Keywords: dysplasia; leukoplakia; oral lesion; malignancy; follow-up Oral dysplasia is a relatively common premalignant condition, which affects approximately 2.5 to 5 per 1000 of population. It is usually seen by general medical and dental practitioners in the form of leukoplakia (a white patch that does not rub off), which affects 1% to 2.5% of the population at any one time. 1 Oral dysplasia can only be diagnosed histologically. In oral dysplasia, cells of the normal oral epithelium are replaced by cells showing immature or inappropriate differentiation with a resemblance to cells usually seen in malignancy. 2 The importance of oral dysplasia lies in that a proportion of these lesions can progress to cancer. However, reports on the risk of progression to cancer vary considerably from 6% to 36%. 3 At present, the only effective treatment is surgical excision, and there are no effective 1600 Treatment and Follow-Up of Oral Dysplasia HEAD & NECK DOI /hed December 2009

2 medical treatments. 4 Even surgical excision carries a high risk of recurrence (up to 35%). 5 Furthermore, resection of large lesions can cause significant morbidity and may sometimes require extensive reconstructive techniques. As a result of these controversies, there is currently no consensus over the treatment and follow-up required for patients with oral dysplasia. Management strategies vary from incisional biopsy aiming to exclude cancer to complete excision with an adequate margin. Reported follow-up strategies vary from immediate discharge to life-time follow-up. 6 To develop an evidence-based management and surveillance policy for oral dysplasia, we undertook a systematic review and meta-analysis of observational cohort and case-controlled studies to assess the risk of and interval to progression to cancer in patients diagnosed with oral dysplasia. We also examined the effects that histologic grade, clinical risk factors, and treatment strategies may have on this. PATIENTS AND METHODS Search Strategy. In accord with the meta-analysis of observational studies in epidemiology (MOOSE) guidelines, the investigators searched Medline (1966 to June 2008), Embase (1980 to June 2008), and Cochrane databases (CENTRAL, Cochrane Library, 1995 to June 2008). The last search was performed on June 4, Our core search terms were oral and dysplasia, mouth and dysplasia. Each of the searches were then combined with each of the following terms: progression, follow-up, treatment, cohort, natural history, and recurrence (Table 1). Reference lists of obtained studies, personal reference lists, and existing reviews were also searched manually. Selection Criteria. To be included in the review, studies had to report on patients with a histologically confirmed diagnosis of oral dysplasia. They also had to study at least one of the outcome measures and one intervention method or clinical risk factor. In studies on oral lesions which contained a defined subset of patients with oral dysplasia, this subset but not all patients with oral lesions were included in the meta-analysis. Observational studies were included in the review because there was a paucity of randomized controlled trials with adequate follow-up. For multiple publications Table 1. Description of search strategy. No. Search term 1 Dysplasia and oral 2 Dysplasia and mouth 3 1 or and progression 5 3 and follow-up 6 3 and treatment 7 3 and cohort 8 3 and natural history 9 3 and recurrence for the same patient group, the data for the longest follow-up period were used. When an abstract was published but no full study was found, it was agreed that the authors would be contacted, but no such instances were identified from the search. Studies that reported on patients with oral leukoplakia without histologically confirmed diagnosis of dysplasia were excluded. Cross-sectional studies of the prevalence of oral dysplasia were also excluded. Data from studies in which patients with dysplasia were not reported separately or could not be extracted from the provided data were excluded. Patients with synchronous cancer at or identified within 3 months of the time of diagnosis of dysplasia were also excluded from the meta-analysis. Studies with less than 1 year follow-up were also excluded. Outcome Measures. The following outcome measures were extracted from the studies, as they were clinically relevant: the rate of malignant transformation to oral cancer and the time interval or duration to malignant transformation. Where available, data were subclassified by histologic grade of the lesion (mild, moderate, severe dysplasia, or carcinoma in-situ [CIS]) and by management strategy (surgical excision or incisional biopsy). The relative risks of malignant transformation for proven or potential clinical risk factors of progression gender, site of lesion, continuation of smoking, and alcohol intake were also extracted. Data Abstraction. Eligibility of the studies obtained from the search was determined independently from the abstracts by two reviewers (T.R., J.S.) blinded to each other s selections. Both reviewers underwent a training period in which 10 studies were assessed together with the lead author (H.M.). If a citation was deemed Treatment and Follow-Up of Oral Dysplasia HEAD & NECK DOI /hed December

3 eligible by at least one reviewer, the article was subjected to review. Data were then extracted from the studies into a Microsoft Excel spreadsheet. Quality and Confounding Assessment. As there is no validated tool for assessing quality in systematic reviews of observational studies, quality criteria were agreed upon a priori, adapted from the levels of evidence for prognostic studies, 7 and adapted from Greenhalgh, 8 Khan et al, 9 and Laupacis et al. 10 Included in the criteria were attempts to address confounding factors within individual studies, length and rate of follow-up achieved, and blinding of assessment of outcome. The quality of the studies was assessed independently by two reviewers (T.R., J.S.). When there was disagreement, a third reviewer (H.M.) was consulted. Statistical Analysis. Outcome data were abstracted independently by a researcher (T.R.) and a statistician (C.M.) and checked by a third reviewer (H.M.). A funnel plot was generated showing individual MTRs in each study by study size. In this plot, the rates are variance-stabilized using the arc-sine square-root transformation because most were below 20%. Heterogeneity was assessed graphically in the forest plot and the exact binomial confidence intervals (CIs) were calculated. Where sufficient data existed, heterogeneity was studied in the statistical model. Transformation rates were modeled by applying a random effects logistic regression model that assumed a fixed effect of the underlying mean log-odds of transformation rate with a random study effect. This allowed estimates of the underlying mean and of the effect of covariates such as dysplasia grade and clinical risk factors. When analyzing effects of dysplasia grade, the mild and moderate subgroups were almagamated, as were severe dysplasia and CIS. This was done because it is widely acknowledged that histological grading of oral dysplasia shows significant intraobserver and interobserver variability, especially for the two diagnoses in each group. 11 RESULTS Description of Studies. The search strategy produced 2837 articles in total, of which 28 were deemed eligible and subjected to full review (Figure 1). After applying the selection criteria, eight cross-sectional studies and four observational cohort studies on oral lesions without histologically confirmed dysplasia were excluded There were no randomized-controlled trials or case-control studies. After exclusion of two studies FIGURE 1. Flowchart of search results. [Color figure can be viewed in the online issue, which is available at wiley.com.] 1602 Treatment and Follow-Up of Oral Dysplasia HEAD & NECK DOI /hed December 2009

4 due to duplication of data, 16,17 14 prospective and retrospective studies were identified (Figure 1). In total, these reported on 992 patients who satisfied our inclusion criteria (Table 2). Mean or median age of the study population ranged from 47.5 to 60.8 years and was given in 7 studies. In the absence of access to individual patient data, it is important to note that these averages were derived from averages given for all patients in those studies which reported on all oral leukoplakia lesions and not just from patients with confirmed dysplasia. Median or mean follow-up ranged from 1.5 to 10 years and was stated in all but 1 study. Minimum follow-up, reported in 7 studies, is short, ranging between 6 and 12 months. Malignant transformation rate (MTR) was reported in all studies. Subgroup analysis by histologic grade was reported by 9 studies. Seven studies reported time interval to malignant transformation (TMR). Surgical treatment of dysplastic lesions by excision was specified in only 5 of 14 studies. The remaining 9 studies reported on biopsy-confirmed lesions without surgical excision. The association of malignant progression with clinical risk factors was reported in 4 studies. Quality Assessment of Studies. Three studies were population based. There were 2 prospective studies from India (level 1 evidence), 30,32 and 1 retrospective study from Northern Ireland (level 2). 21 The remainder of studies were single-institution case series from Eastern Asia, North America, and Western Europe (level 4). They used pathology slides, medical, or questionnaires sent to medical and dental practitioners to collate data. The results of the quality assessment of the studies are summarized in Table 3. Malignant Transformation and Heterogeneity of Studies. The pooled estimate for the mean MTR for all studies is 12.1% (CI: 8.1%, 17.9%), with a wide variation between studies (0% 36.4%). The rate is little affected by the mean follow-up time of the study (p ¼.26; Figure 2). To assess possible bias in the studies and examine heterogeneity, a funnel plot is shown (Figure 3). In this plot, the studies individual MTRs are variance-stabilized using the arc-sine square-root transformation because most were below 20%. The meta-analysis shows a degree of heterogeneity between studies when comparing Table 2. Description of studies included in the meta-analysis. Nonsurgically treated patients Surgical excision patients Total dysplasia patients Mean or median age, y Min. follow-up, Mean follow-up, y y Date of enrollment Methodology and setting Study Country Hsue et al 18 Taiwan Prospective hospital NR Holmstrup et al 19 Denmark Retrospective hospital Saito et al 20 Japan Retrospective hospital Cowan et al 21 Northern Ireland Retrospective population NR NR NR Lee et al 22 USA Prospective hospital NR NR Schepman et al 23 The Netherlands Retrospective hospital Lumerman et al 24 USA Retrospective pathology laboratory Hogewind et al 25 The Netherlands Retrospective hospital NR Lind 26 Norway Retrospective hospital NR Silverman et al 27 USA Prospective hospital <1968? Gupta et al 28 India Prospective population 1966? 8.5 NR NR Banoczy and Csiba 29 Hungary Retrospective hospital Not clear 6.3 NR NR Silverman et al 30 India Prospective population NR > Mincer et al 31 USA Prospective hospital NR All studies Abbreviations: min, minimum; NR, not reported. Treatment and Follow-Up of Oral Dysplasia HEAD & NECK DOI /hed December

5 Study* Methodology and setting Hsue et al 18 Prospective hospital Holmstrup Retrospective et al 19 hospital Saito et al 20 Retrospective hospital Cowan et al 21 Retrospective population Lee et al 22 Prospective hospital Schepman Retrospective et al 23 hospital Lumerman Retrospective et al 24 pathology laboratory Hogewind Retrospective et al 25 hospital Lind 26 Retrospective hospital Silverman Prospective et al 27 hospital Gupta et al 28 Prospective population Table 3. Quality assessment of studies included in review. Level of evidence Assessment of exposure (dysplasia) Sampling method bias Cohort characteristics Method of outcome assessment (cancer) Blinding of outcome assessment Adequacy of follow-up rate >80% Comments 4 Pathology 4 Medical 4 Medical 2 Pathology slides Yes All patients smoked and chewed betel; cancer within 6 months excluded Yes Concurrent cancer excluded; all smokers encouraged to quit Yes Nonsurgical treatments included cryotherapy and laser No Concurrent cancer excluded; slides were reviewed and reclassified if necessary 4 Biopsy Yes All patients received high-dose isotretinoin followed by low-dose isotretinoin versus beta-carotene maintenance 4 Pathology Yes Concurrent and previous malignancy excluded 4 Biopsy Yes Slides were reviewed and reclassified if necessary 4 Medical 4 Pathology Medical No Yes Data set checked against national cancer registry to allow for drop-outs Medical No No Surgical versus non-surgical treatment was not randomized Medical No No Surgical versus nonsurgical treatment was not randomized Medical No Yes Data for all malignant transformers available; 7 of 24 transformed in 1mohence excluded Biopsy No Yes Sample includes patients with hyperplastic lesions in high-risk sites Medical No No Not subdivided by grade of dysplasia Questionnaire administered to dental practitioners No No Only about 25% response rate to follow-up questionnaire Yes Concurrent cancer excluded Medical No No Some lesions treated by cryosurgery Yes Concurrent cancer excluded Medical No Yes Data set checked 4 Biopsy Yes Lesions > 1 cm size, persistent for > 6 months, concurrent cancer excluded 1 Biopsy No Random sample from villagers in 5 Indian districts, varying Biopsy No Yes against national cancer registry to allow for drop-outs Biopsy No Yes Ten-year follow-up study but patients (Continued) 1604 Treatment and Follow-Up of Oral Dysplasia HEAD & NECK DOI /hed December 2009

6 Table 3. Quality assessment of studies included in review (Continued). Adequacy of follow-up rate >80% Comments Blinding of outcome assessment Method of outcome assessment (cancer) Cohort characteristics Sampling method bias Assessment of exposure (dysplasia) Level of evidence Methodology and setting Study* recruited during first 3 years of study hence shorter mean follow-up tobacco habits, in excess of 50,000 villagers examined 4 Biopsy Yes Large male preponderance Medical No No Banoczy and Retrospective Csiba 29 hospital Biopsy No Yes 1 Biopsy No Sample of 6718 industrial workers in Gujarat, India Biopsy No No Excluded all mild dysplasias from follow-up Yes Sample under study was part of 50,000 patients in an oral cytology programme at university center, cancer within 12 months excluded 4 Pathology Silverman et al 30 Prospective population Mincer et al 31 Prospective hospital *Studies included in meta-analysis. MTR against study size, but there is little evidence of the asymmetry of publication bias. If the 3 outliers in the funnel plot are excluded, all of which are prospective studies, 22,30,33 the overall MTR for all studies and CI are reduced slightly (11.3%; CI: 8.4%, 15.1%). Malignant Transformation and Histologic Grade. Table 4 shows a clear difference between the transformation rate for mild to moderate dysplasia, estimated from the logistic model as 10.3%, (CI: 6.1, 16.8%), compared with severe dysplasia and CIS, and 24.1% (13.3, 39.5%; p <.008). Malignant Transformation and Treatment Modality- Patients whose lesions were not excised surgically reported considerably higher overall transformation rates when compared with patients who underwent surgical excision (14.6% vs 5.4%). After adjusting for grade in the logistic model, this was still statistically significant (p ¼.003). Time Interval to Malignant Transformation. Seven studies reported on the time interval to malignant transformation. In studies including all oral leukoplakia, this mean time interval applied to all lesions and not just lesions with dysplasia. Only 4 studies provided data specifically for dysplastic lesions (mean, 4.3 years; range, years; data not shown). Subgroup analysis by dysplasia grade and treatment modality showed no significant differences in TMT. Relative Risk in Relation to Clinical Risk Factors. The risk factors gender, smoking status, alcohol, and site of lesions were evaluated in 4 different studies in total. From the limited data available, there appears to be a trend for malignant progression to be associated with lesions of the tongue (relative risk [RR] ¼ 1.87; CI: 1.11, 3.17), whereas continuing smoking and alcohol use after diagnosis appears to have no effect on malignant transformation (Table 5). However, the 2 studies with data on smoking are nonhomogenous (p ¼.008, Breslow-Day test). DISCUSSION Principal Findings. Oral dysplasia carries a significant rate of transformation to cancer Treatment and Follow-Up of Oral Dysplasia HEAD & NECK DOI /hed December

7 FIGURE 2. Forest plot with calculated exact binomial confidence intervals of malignant transformation rate of oral dysplastic lesions for studies included in the meta-analysis. (12.3%). This increases considerably for highgrade dysplasia (severe dysplasia and carcinomain-situ). Furthermore, surgical excision appears to decrease the risk of transformation by more than half, but does not eliminate it. This suggests the need for continued surveillance, especially for high-grade dysplastic lesions, even after surgical excision. There was insufficient information in the studies to formally assess the effect of clinical risk factors, such as smoking and alcohol, on progression to malignancy. This systematic review demonstrated significant heterogeneity between follow-up studies. It also showed a distinct lack of randomized controlled trials examining different surgical management and follow-up protocols, especially in view of the wide variations in clinical practice that prevail in these areas. study selection, and presentation of results and discussion. 34 The possibility of publication bias remained a problem for all systematic reviews. This review was limited by the paucity of high-quality follow-up studies. The meta-analysis is therefore of the best available evidence. This may compound the methodological deficiencies of the original studies, most importantly, referral bias seen in single-center cohorts, and short followup. There are differences between the included Strengths and Limitations. This systematic review has concentrated on the long-term risk of malignant transformation and follow-up of oral dysplastic lesions. This is an area of clinical practice that showed great variability and lacks high-quality evidence. The search strategy was therefore extended to include nonrandomized studies. This systematic review complies with the MOOSE statement, which includes detailed guidelines on formulating the clinical problem, search strategy and identification of sources, FIGURE 3. Graph of the transformation rate (arcsine transformed) against study size, a form of meta-analysis funnel plot in which the study rates should lie mainly within the 95% confidence interval lines. It shows a degree of heterogeneity (they should be more clustered toward the center). The 3 outliers are Lee et al, 22 Silverman et al, 27 and Silverman et al Treatment and Follow-Up of Oral Dysplasia HEAD & NECK DOI /hed December 2009

8 Study* Table 4. Malignant transformation rates for all studies. Total dysplasia Mild Mod Severe CIS Malignant transform (No. of patients) Mild Mod Severe CIS MTR Hsue et al NR NR 4.8% Holmstrup et al % Saito et al NR NR 7.7% Cowan et al NR 17 NR 14.5% Lee et al NR NR 31.4% Schepman et al Not subdivided 12 Not subdivided 21.8% Lumerman et al % Hogewind et al NR NR 7.7% Lind NR NR 17.0 % Silverman et al NR 8 NR 36.4% Gupta et al NR 6 NR 6.7% Banoczy and Csiba NR NR 13.2% Silverman et al NR 0 NR 0.0% Mincer et al Omitted NR 5 Omitted 2 3 NR 11.1% Abbreviations: mod, moderate; CIS, carcinoma-in-situ; MTR, malignant transformation rates; NR, not reported. studies in their design, inclusion criteria, patient population (including ethnicity), patient management, length of follow-up, and analysis of patient risk factors, all of which may have an effect on outcomes. However, combining the relatively scarce data that are available has made it possible to provide a better understanding of the overall behavior of oral dysplasia. The meta-analysis used published data and not original patient data, as many of the studies were conducted in the 1970s and 1980s. This can affect the quality of the meta-analysis. In particular, it has impeded the ability to perform subgroup analyses, especially for TMT and clinical risk factors. The former is likely to be confounded by length of follow-up and the latter by age and grade of the dysplastic lesions. It was demonstrated that there are statistically significant differences in progression rates between the various grades of oral dysplasia. However, it is widely acknowledged that histologic grading of oral dysplasia shows significant intraobserver and interobserver variability. 11 Therefore, it is impossible to be certain that the lesions included in the same grade by different studies are similar. For this reason, the subgroups mild and moderate, and severe dysplasia and CIS were almagamated. Assessment of the quality of observational studies is difficult, as there is no validated tool currently in wide use. To overcome this problem, the factors that could introduce bias into the meta-analysis were evaluated using a combination of methods Implications for Clinical Practice. Oral dysplasia appears to carry a significant transformation rate to oral cancer, which occurs over a period of years, even when treated by surgical excision. This would suggest that patients should be kept under surveillance after diagnosis for anything up to 20 years. It may be feasible to tailor the duration of the surveillance period, and possibly its frequency, according to several clinical Risk factor Table 5. Relative risk of malignant transformation of oral lesions analyzed by clinical risk factor. Studies reporting Risk factor present Malignant transformation Risk factor absent Malignant transformation RR (CI) Smoking (patient continues to smoke) n/a Alcohol (patient continues to drink) ( ) Site (tongue vs other) ( ) Sex (male vs female) ( ) Abbreviations: RR, relative risk; CI, confidence interval; n/a, not available. Treatment and Follow-Up of Oral Dysplasia HEAD & NECK DOI /hed December

9 factors, including grade of dysplasia, and clinical management (lesions which are not excised). However, the limited data available for this review can neither confirm nor reject the hypothesis that higher grade dysplastic lesions would transform earlier. Implications for Research. Future research is needed in 3 areas. First, research is needed in the search for better prognostic markers for progression from dysplasia to malignancy. This would replace or augment histologic grading to improve the identification of patients at risk of malignant transformation, so that they can be targeted for more aggressive treatment and closer surveillance. Second, future research is needed in the evaluation of follow-up protocols for efficacy and cost-effectiveness, including determination of surveillance duration and frequency. Furthermore, an assessment is required of whether a surveillance policy would influence eventual outcome through earlier diagnosis of recurrence and/or transformation and earlier treatment. Third, future research is needed in the search to identify less invasive and more effective treatments, which would prevent recurrence and progression, without the attendant comorbidity of surgical resection. CONCLUSION Oral dysplasia carries a significant rate of transformation to cancer, which increases considerably for high-grade dysplasia. Surgical excision appears to decrease but does not eliminate the risk. These findings suggest the need for surgical excision and continued surveillance, especially for high-grade lesions. REFERENCES 1. Axell T, Pindborg JJ, Smith CJ, van der Waal I. Oral white lesions with special referenace to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18 21, International Collaborative Group on Oral White Lesions. J Oral Pathol Med 1996;25: Pindborg JJ, Reichart P, Smith CJ, von der Waal I. World Health Organization: histological typing of cancer and precancer of the oral mucosa. Berlin: Springer Verlag; Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 2003;14: Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Interventions for treating oral leukoplakia. Cochrane Database Syst Rev 2006;4:CD van der Waal I, Schepman KP, van der Meij EH, Smeele LE. Oral leukoplakia: a clinico-pathological review. Oral Oncol 1997;33: Epstein JB, Gorsky M, Fischer D, Gupta A, Epstein M, Elad S. A survey of the current approaches to diagnosis and management of oral premalignant lesions. J Am Dent Assoc 2007;138: Oxford Centre for Evidence-Based Medicine. Levels of Evidence. May Available at: cebm.net/ index.aspx?o¼1047. Accessed: June 9, Greenhalgh T. How to read a paper. The basics of evidence based medicine, 2nd edition. London: BMJ Press; Khan KS, ter Riet G, Popay J, Nixon J, Kleijnen J. Study quality assessment. Undertaking systematic reviews of research on effectiveness. CRD s guidance for those carrying out or commissioning reviews. CRD report no. 4, 2nd edition. York: NHS Centre for Reviews and Dissemination; Laupaucis A, Wells G, Richardson WS, Tugwell P. Users guides to the medical literature. V. How to use a article on prognosis. JAMA 1994;272: Abbey LM, Kaugars GE, Gunsolley JC, et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Radiol Endod 1995;80: Banoczy J, Sugar L. Longitudinal studies in oral leukoplakia. J Oral Pathol 1972;1: Mehta FS, Shroff BC, Gupta PC, Daftary DK. Oral leukoplakia in relation to tobacco habits. Oral Surg 1972; 34: Pindborg JJ, Renstrup G, Jolst O, Roed-Petersen B. Studies in oral leukoplakia: a preliminary report on the period prevalence of malignant transformation in leukoplakia based on a follow-up study of 248 patients. J Am Dent Assoc 1968;76: Silverman S, Rozen RD. Observations on the clinical characteristics and natural history of oral leukoplakia. J Am Dent Assoc 1968;76: Pindborg JJ, Daftary DK, Mehta FS. A follow-up study of sixty-one oral dysplastic precancerous lesions in Indian villagers. Oral Surg Oral Med Oral Pathol 1977; 43: Banoczy J. Follow-up studies in oral leukoplakia. J Maxillofac Surg 1977;5: Hsue SS, Wang WC, Chen CH, Lin CC, Chen YK, Lin LM. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med. 2007;36: Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol 2006;42: Saito T, Sugiura C, Hirai A, et al. Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality. Int J Oral Maxillofac Surg 2001;30: Cowan CG, Gregg TA, Napier SS, McKenna SM, Kee F. Potentially malignant oral lesions in Northern Ireland: a 20-year population-based perspective of malignant transformation. Oral Dis 2001;7: Lee JJ, Hong WK, Hittelman WN, et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 2000;6: Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of Treatment and Follow-Up of Oral Dysplasia HEAD & NECK DOI /hed December 2009

10 patients with oral leukoplakia from the Netherlands. Oral Oncol 1998;34: Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Radiol Endod 1995;79: Hogewind WFC, van der Kwast WAM, van der Waal I. Oral leukoplakia, with emphasis on malignant transformation. J Craniomaxillofac Surg 1989;17: Lind PO. Malignant transformation in oral leukoplakia. Scand J Dent Res 1987;95: Silverman S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984;53: Gupta PC, Mehta FS, Daftary DK, et al. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol 1980;8: Banoczy J, Csiba A. Occurrence of epithelial dysplasia in oral dysplasia. Oral Surg 1976;42: Silverman S, Bhargava K, Mani NJ, Smith LW, Malaowalla AM. Malignant transformation and natural history of oral leukoplakia in 57,518 industrial workers of Gujarat India. Cancer 1976;38: Mincer HH, Coleman SA, Hopkins KP. Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia. Oral Surg 1972;33: Gupta PC, Mehta FS, Daftary DK, et al. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol 1980;8: Silverman S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984;53: Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 2000;283: Treatment and Follow-Up of Oral Dysplasia HEAD & NECK DOI /hed December

Review Article Malignant Transformation Rate in Patients Presenting Oral Epithelial Dysplasia: Systematic Review and Meta-Analysis

Review Article Malignant Transformation Rate in Patients Presenting Oral Epithelial Dysplasia: Systematic Review and Meta-Analysis Oral Diseases Volume 2015, Article ID 854636, 10 pages http://dx.doi.org/10.1155/2015/854636 Review Article Malignant Transformation Rate in Patients Presenting Oral Epithelial Dysplasia: Systematic Review

More information

LEUKOPLAKIA Definition Epidemiology Clinical presentation

LEUKOPLAKIA Definition Epidemiology Clinical presentation LEUKOPLAKIA Definition Leukoplakia is the most common premalignant or "potentially malignant" lesion of the oral mucosa. Leukoplakia is a predominantly white lesion of the oral mucosa than cannot be clinicopathologically

More information

Long-term treatment outcome of oral premalignant lesions

Long-term treatment outcome of oral premalignant lesions Oral Oncology (2005) xxx, xxx xxx ARTICLE IN PRESS http://intl.elsevierhealth.com/journals/oron/ Long-term treatment outcome of oral premalignant lesions P. Holmstrup a, *, P. Vedtofte b, J. Reibel a,

More information

Conclusion: It was concluded that laser provides good coagulation, healing, reduces surgical time and prevents high-grade infection.

Conclusion: It was concluded that laser provides good coagulation, healing, reduces surgical time and prevents high-grade infection. Research AHB Article Adv Hum Biol 2014; 4(2):45-49. Clinical and Histopathological Evaluation of Healing After Excision of Leukoplakia with Diode Laser Kruti A Shah 1* Hemal R Brahmkshatriya 2 Rushit J

More information

Is there any benefit in surgery for potentially malignant disorders of the oral cavity?

Is there any benefit in surgery for potentially malignant disorders of the oral cavity? doi: 10.1111/jop.12088 (2014) 43: 239 244 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd wileyonlinelibrary.com/journal/jop REVIEW ARTICLE Is there any benefit in surgery for potentially

More information

Potentially malignant oval lesions in northern ireland: a 20-year population-based perspective of malignant transformation

Potentially malignant oval lesions in northern ireland: a 20-year population-based perspective of malignant transformation Potentially malignant oval lesions in northern ireland: a 20-year population-based perspective of malignant transformation Cowan, G., Gregg, T. A., Napier, S. S., McKenna, S. M., & Kee, F. (2001). Potentially

More information

Feasibility of recruitment to an oral dysplasia trial in the United Kingdom

Feasibility of recruitment to an oral dysplasia trial in the United Kingdom Nankivell et al. Head & Neck Oncology 2012, 4:40 RESEARCH Open Access Feasibility of recruitment to an oral dysplasia trial in the United Kingdom Paul Nankivell 1,2, Janet Dunn 3, Michael Langman 4 and

More information

Newcastle University eprints

Newcastle University eprints Newcastle University eprints Diajil A, Robinson CM, Sloan P, Thomson PJ. (23) Clinical Outcome Following Oral Potentially malignant Disorder Treatment: A patient Cohort Study. International Dentistry Volume

More information

Malignant Transformation in Leukoplakia and its Associated Factors in Southern Iran: A Hospital Based Experience

Malignant Transformation in Leukoplakia and its Associated Factors in Southern Iran: A Hospital Based Experience Iran J Public Health, Vol. 46, No.8, Aug 2017, pp.1110-1117 Original Article Malignant Transformation in Leukoplakia and its Associated Factors in Southern Iran: A Hospital Based Experience Alireza BARFI

More information

Oral Leukoplakia Related to Malignant Transformation

Oral Leukoplakia Related to Malignant Transformation Oral Science International, November 6, p.45 55 Copyright 6, ese Stomatology Society. All Rights Reserved. Review Article Oral Leukoplakia Related to Malignant Transformation Teruo Amagasa, Masashi Yamashiro

More information

Malignant transformation of oral submucous fibrosis in Taiwan: A nationwide population-based retrospective cohort study

Malignant transformation of oral submucous fibrosis in Taiwan: A nationwide population-based retrospective cohort study Accepted: 9 March 2017 DOI: 10.1111/jop.12570 ORIGINAL ARTICLE Malignant transformation of oral submucous fibrosis in Taiwan: A nationwide population-based retrospective cohort study Po-Yu Yang 1,2 Yi-Tzu

More information

Smoking Habits Among Patients Diagnosed with Oral Lichen Planus

Smoking Habits Among Patients Diagnosed with Oral Lichen Planus TOBACCO INDUCED DISEASES Vol. 2, No. 2: 103-108 (2004) PTID Society Smoking Habits Among Patients Diagnosed with Oral Lichen Planus Meir Gorsky, 1 Joel B. Epstein, 2 Haya Hasson-Kanfi, 1 Eliezer Kaufman

More information

The role of interventional surgery in oral potentially malignant disorders by Peter Thomson

The role of interventional surgery in oral potentially malignant disorders by Peter Thomson 84 Peter Thomson DOI 10.1308/204268514X13939420839142 The role of interventional surgery in oral potentially malignant disorders by Peter Thomson Oral potentially malignant disorders are mucosal diseases

More information

Original Research Article

Original Research Article ASSESSMENT OF HUMAN PAPILLOMA VIRUS SUBTYPES BY POLYMERASE CHAIN REACTION AND THEIR IMPACT ON THE DEGREE OF DYSPLASIA IN ORAL LEUKOPLAKIA Submitted on: XXXX Dr. N. Kannan, Dr Teja Srinivas, Dr. Rakesh

More information

Epidemiological and clinicopathological study of oral leukoplakia

Epidemiological and clinicopathological study of oral leukoplakia Study Epidemiological and clinicopathological study of oral Minati Mishra, Janardan Mohanty*, Sujata Sengupta, Satyabrata Tripathy Department of Dermatology & Venereology, S.C.B. Medical College, *Department

More information

PACIFIC JOURNAL OF MEDICAL SCIENCES {Formerly: Medical Sciences Bulletin} ISSN:

PACIFIC JOURNAL OF MEDICAL SCIENCES {Formerly: Medical Sciences Bulletin} ISSN: PACIFIC JOURNAL OF MEDICAL SCIENCES {Formerly: Medical Sciences Bulletin} ISSN: 2072 1625 Pac. J. Med. Sci. (PJMS) www.pacjmedsci.com. Email: pacjmedsci@gmail.com. BILATERAL RECURRENT SPECKLED LEUKOPLAKIA:

More information

American Journal of Cancer Science

American Journal of Cancer Science American Journal of Cancer Science http://ivyunion.org/index.php/ajcs/ Akerzoul N et al. American Journals of Cancer Science 2015, 5:63-77 Page 1 of 6 Case Report Malignant Transformation of Erosive Oral

More information

The Prevalence of Oral Leukoplakia: Results From a Romanian Medical Center

The Prevalence of Oral Leukoplakia: Results From a Romanian Medical Center The Prevalence of Oral Leukoplakia: Results From a Romanian Medical Center Ramona Vlad, DMD Department of Odontology and Oral Pathology, Faculty of Dental Medicine, University of Medicine and Pharmacy

More information

The sensitivity and specificity of the OralCDx technique: evaluation of 103 cases

The sensitivity and specificity of the OralCDx technique: evaluation of 103 cases Oral Oncology (2004) 40 824 828 http://intl.elsevierhealth.com/journals/oron/ The sensitivity and specificity of the OralCDx technique: evaluation of 103 cases Christian Scheifele *, Andrea-Maria Schmidt-Westhausen,

More information

Dysplasia of the Upper Aerodigestive Tract Squamous Epithelium

Dysplasia of the Upper Aerodigestive Tract Squamous Epithelium Head and Neck Pathol (2009) 3:63 68 DOI 10.1007/s12105-009-0103-8 PROCEEDINGS OF THE 2009 NORTH AMERICAN SOCIETY OF HEAD AND NECK PATHOLOGY COMPANION MEETING (BOSTON, MA) Dysplasia of the Upper Aerodigestive

More information

Assessment of Clinical Risk Factors of Oral Leukoplakia in UP Population of India: An Institutional Study

Assessment of Clinical Risk Factors of Oral Leukoplakia in UP Population of India: An Institutional Study 230 Int J Oral-Med Sci 12(4):230-234, 2014 Original Article Assessment of Clinical Risk Factors of Oral Leukoplakia in UP Population of India: An Institutional Study Preeti Sharma, Pooja Aggarwal, and

More information

Workshop: Cochrane Rehabilitation 05th May Trusted evidence. Informed decisions. Better health.

Workshop: Cochrane Rehabilitation 05th May Trusted evidence. Informed decisions. Better health. Workshop: Cochrane Rehabilitation 05th May 2018 Trusted evidence. Informed decisions. Better health. Disclosure I have no conflicts of interest with anything in this presentation How to read a systematic

More information

Gomes CC, Gomez RS. Oral leukoplakia: What is achieved by surgical treatment? Annals of Oral & Maxillofacial Surgery 2013 Feb 01;1(1):9.

Gomes CC, Gomez RS. Oral leukoplakia: What is achieved by surgical treatment? Annals of Oral & Maxillofacial Surgery 2013 Feb 01;1(1):9. Gomes CC, Gomez RS. Oral leukoplakia: What is achieved by surgical treatment? Annals of Oral & Maxillofacial Surgery 2013 Feb 01;1(1):9. Licensee OA Publishing London 2013. Creative Commons Attribution

More information

Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist.

Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist. Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist. MOOSE Checklist Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease:

More information

Dentition, oral hygiene, and risk of oral cancer: a case-control study in Beijing, People's Republic of China

Dentition, oral hygiene, and risk of oral cancer: a case-control study in Beijing, People's Republic of China Cancer Causes and Control 1, 235-241 Dentition, oral hygiene, and risk of oral cancer: a case-control study in Beijing, People's Republic of China Tongzhang Zheng, Peter Boyle, Huanfang Hu, Jun Duan, Peijue

More information

Factors affecting Clinical Outcomes after Treatment of Oral Leukoplakia with CO 2 and Diode Laser

Factors affecting Clinical Outcomes after Treatment of Oral Leukoplakia with CO 2 and Diode Laser JCDP ORIGINAL RESEARCH Factors affecting Clinical Outcomes 10.5005/jp-journals-10024-2125 after Treatment of Oral Leukoplakia Factors affecting Clinical Outcomes after Treatment of Oral Leukoplakia with

More information

PROSPERO International prospective register of systematic reviews

PROSPERO International prospective register of systematic reviews PROSPERO International prospective register of systematic reviews Closed reduction methods for acute anterior shoulder dislocation [Cochrane Protocol] Kanthan Theivendran, Raj Thakrar, Subodh Deshmukh,

More information

Surveillance report Published: 17 March 2016 nice.org.uk

Surveillance report Published: 17 March 2016 nice.org.uk Surveillance report 2016 Ovarian Cancer (2011) NICE guideline CG122 Surveillance report Published: 17 March 2016 nice.org.uk NICE 2016. All rights reserved. Contents Surveillance decision... 3 Reason for

More information

Systematic Reviews and Meta- Analysis in Kidney Transplantation

Systematic Reviews and Meta- Analysis in Kidney Transplantation Systematic Reviews and Meta- Analysis in Kidney Transplantation Greg Knoll MD MSc Associate Professor of Medicine Medical Director, Kidney Transplantation University of Ottawa and The Ottawa Hospital KRESCENT

More information

Title: Meta-analysis of Individual patient Data (IPD) of Patients with INH (mono or poly-drug) Resistant Tuberculosis.

Title: Meta-analysis of Individual patient Data (IPD) of Patients with INH (mono or poly-drug) Resistant Tuberculosis. Title: Meta-analysis of Individual patient Data (IPD) of Patients with INH (mono or poly-drug) Resistant Tuberculosis. Principal Investigator: Dick Menzies, MD Evidence base for treatment of INH resistant

More information

Topical photodynamic therapy is very effective for oral verrucous hyperplasia and oral erythroleukoplakia

Topical photodynamic therapy is very effective for oral verrucous hyperplasia and oral erythroleukoplakia J Oral Pathol Med (2010) 39: 624 630 ª 2010 John Wiley & Sons A/S Æ All rights reserved doi: 10.1111/j.1600-0714.2010.00935.x interscience.wiley.com/journal/jop Topical photodynamic therapy is very effective

More information

HPV and p53 expression in dysplastic lesions and squamous carcinomas of the oral mucosa

HPV and p53 expression in dysplastic lesions and squamous carcinomas of the oral mucosa Romanian Journal of Morphology and Embryology 2005, 46(2):155 159 HPV and p53 expression in dysplastic lesions and squamous carcinomas of the oral mucosa CRISTIANA SIMIONESCU 1), CL. MĂRGĂRITESCU 1), CLAUDIA

More information

Mouth Cancer in India A New Epidemic? Prakash C. Gupta. Epidemiology Research Unit, Tata Institute of Fundamental Research, Mumbai

Mouth Cancer in India A New Epidemic? Prakash C. Gupta. Epidemiology Research Unit, Tata Institute of Fundamental Research, Mumbai For the Journal of the Indian Medical Association Mouth Cancer in India A New Epidemic? Prakash C. Gupta Epidemiology Research Unit, Tata Institute of Fundamental Research, Mumbai Correspondence to Dr.

More information

R. Diagnostic criteria in proliferative verrucous leukoplakia: Evaluation.

R. Diagnostic criteria in proliferative verrucous leukoplakia: Evaluation. Journal section: Oral Medicine and Pathology Publication Types: Research doi:10.4317/medoral.19424 http://dx.doi.org/doi:10.4317/medoral.19424 Diagnostic criteria in proliferative verrucous leukoplakia:

More information

Between-Lesion Discrepancies in Terms of Dysplasia, Cell Turnover and Diagnosis in Patients with Multiple Potentially Malignant Oral Lesions

Between-Lesion Discrepancies in Terms of Dysplasia, Cell Turnover and Diagnosis in Patients with Multiple Potentially Malignant Oral Lesions Send Orders for Reprints to reprints@benthamscience.net The Open Dentistry Journal, 2013, 7, 169-174 169 Open Access Between-Lesion Discrepancies in Terms of, Cell Turnover and in Patients with Multiple

More information

Peritoneal Involvement in Stage II Colon Cancer

Peritoneal Involvement in Stage II Colon Cancer Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.

More information

STUDY OF ORAL EXFOLIATIVE CYTOLOGY IN TOBACCO CHEWERS OF WESTERN INDIA

STUDY OF ORAL EXFOLIATIVE CYTOLOGY IN TOBACCO CHEWERS OF WESTERN INDIA Page138 Research Article Biological Sciences STUDY OF ORAL EXFOLIATIVE CYTOLOGY IN TOBACCO CHEWERS OF WESTERN INDIA Archana Chirag Buch 1, Smit Sanjaybhai Patel 2, Shirish S. Chandanwale 3, Harsh Kumar

More information

Department of Pathology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, India 2

Department of Pathology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, India 2 original article Oman Medical Journal [2016], Vol. 31, No. 3:165 169 Transition of Immunohistochemical Expression of E-Cadherin and Vimentin from Premalignant to Malignant Lesions of Oral Cavity and Oropharynx

More information

PROSPERO International prospective register of systematic reviews

PROSPERO International prospective register of systematic reviews PROSPERO International prospective register of systematic reviews Prophylactic cranial irradiation in patients with non-small-cell lung cancer: a systematic review and meta-analysis of randomized controlled

More information

Design and Analysis of a Cancer Prevention Trial: Plans and Results. Matthew Somerville 09 November 2009

Design and Analysis of a Cancer Prevention Trial: Plans and Results. Matthew Somerville 09 November 2009 Design and Analysis of a Cancer Prevention Trial: Plans and Results Matthew Somerville 09 November 2009 Overview Objective: Review the planned analyses for a large prostate cancer prevention study and

More information

Abstract Background: A wide variety of white lesions are encountered in general population and specially those people

Abstract Background: A wide variety of white lesions are encountered in general population and specially those people Original Article Assessment of white lesion in known population group: A Pilot Study Vandana Katoch 1, Sandeep Sidhu 2, Amit Kour 3, Saurav Saini 4, Priyanka Sharma 5 1 MDS, Department Of Oral and Maxillofacial

More information

Analysis of the outcome of young age tongue squamous cell carcinoma

Analysis of the outcome of young age tongue squamous cell carcinoma Jeon et al. Maxillofacial Plastic and Reconstructive Surgery (2017) 39:41 DOI 10.1186/s40902-017-0139-8 Maxillofacial Plastic and Reconstructive Surgery RESEARCH Open Access Analysis of the outcome of

More information

Data extraction. Specific interventions included in the review Dressings and topical agents in relation to wound healing.

Data extraction. Specific interventions included in the review Dressings and topical agents in relation to wound healing. Systematic reviews of wound care management: (2) dressings and topical agents used in the healing of chronic wounds Bradley M, Cullum N, Nelson E A, Petticrew M, Sheldon T, Torgerson D Authors' objectives

More information

Original Research. Serum lipid profile in oral precancer and cancer...garg D et al

Original Research. Serum lipid profile in oral precancer and cancer...garg D et al Journal of International Oral Health 14; 6(2):33-39 Received: 1th August 13 Accepted: 15th December 13 Conflict of Interest: one Source of Support: il Original Research Serum lipid profile in oral precancer

More information

The relevance of uniform reporting in oral leukoplakia: Definition, certainty factor and staging based on experience with 275 patients

The relevance of uniform reporting in oral leukoplakia: Definition, certainty factor and staging based on experience with 275 patients Journal section: Oral Medicine and Pathology Publication Types: Research doi:10.4317/medoral.18756 http://dx.doi.org/doi:10.4317/medoral.18756 The relevance of uniform reporting in oral leukoplakia: Definition,

More information

Treatment results of CO 2 laser vaporisation in a cohort of 35 patients with oral leukoplakia

Treatment results of CO 2 laser vaporisation in a cohort of 35 patients with oral leukoplakia (2013) 19, 212 216 doi:10.1111/odi.12007 2012 John Wiley & Sons A/S All rights reserved www.wiley.com ORIGINAL ARTICLE Treatment results of CO 2 laser vaporisation in a cohort of 35 patients with oral

More information

PROSPERO International prospective register of systematic reviews

PROSPERO International prospective register of systematic reviews PROSPERO International prospective register of systematic reviews Meta-analysis of randomized controlled trials in first-line treatment of squamous non-small cell lung cancer Lisa Hess, Amy De Lozier,

More information

The QUOROM Statement: revised recommendations for improving the quality of reports of systematic reviews

The QUOROM Statement: revised recommendations for improving the quality of reports of systematic reviews The QUOROM Statement: revised recommendations for improving the quality of reports of systematic reviews David Moher 1, Alessandro Liberati 2, Douglas G Altman 3, Jennifer Tetzlaff 1 for the QUOROM Group

More information

King s Research Portal

King s Research Portal King s Research Portal DOI: 10.1111/jop.12603 Document Version Peer reviewed version Link to publication record in King's Research Portal Citation for published version (APA): Alaizari, N. A., Sperandio,

More information

SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY IN THE ELDERLY

SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY IN THE ELDERLY ORIGINAL ARTICLE SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY IN THE ELDERLY Yi-Shing Leu 1,2,3 *, Yi-Fang Chang 4, Jehn-Chuan Lee 1, Chung-Ji Liu 2,5,6, Hung-Tao Hsiao 7, Yu-Jen Chen 8, Hong-Wen Chen 8,9,

More information

Evaluation of Mirror Image Biopsy for Incidence of Multiple Premalignant and Malignant Lesions in Oral Cancer: A Clinical Study

Evaluation of Mirror Image Biopsy for Incidence of Multiple Premalignant and Malignant Lesions in Oral Cancer: A Clinical Study 10.5005/jp-journals-10011-1294 Manjula A Hebbale et al ORIGINAL ARTICLE Evaluation of Mirror Image Biopsy for Incidence of Multiple Premalignant and Malignant Lesions in Oral Cancer: A Clinical Study Manjula

More information

Open Access Predictive Role of p53 Protein as a Single Marker or Associated with ki67 Antigen in Oral Leukoplakia: A Retrospective Longitudinal Study

Open Access Predictive Role of p53 Protein as a Single Marker or Associated with ki67 Antigen in Oral Leukoplakia: A Retrospective Longitudinal Study Send Orders for Reprints to reprints@benthamscience.ae The Open Dentistry Journal, 2015, 9, 41-45 41 Open Access Predictive Role of p53 Protein as a Single Marker or Associated with ki67 Antigen in Oral

More information

Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Squamous Cell Carcinoma of the Head and Neck (SCCHN) Squamous Cell Carcinoma of the Head and Neck (SCCHN) Part 1 Bruce M. Wenig, M.D. Dept. of Pathology & Laboratory Medicine Continuum Health Partners New York, NY College of American Pathologists 2004. Materials

More information

Clinical behaviour of malignant transforming oral lichen planus

Clinical behaviour of malignant transforming oral lichen planus EJSO 2002; 28: 838±843 doi:10.1053/ejso.2002.1302, available online at http://www.idealibrary.com on 1 Clinical behaviour of malignant transforming oral lichen planus M. D. Mignogna*, L. Lo Russo*, S.

More information

Diagnostic difficulties with lesions of the oral mucosa

Diagnostic difficulties with lesions of the oral mucosa BDIAP London, November 2010 School of Clinical Dentistry University of Sheffield Diagnostic difficulties with lesions of the oral mucosa Paul M Speight Dept Oral & Maxillofacial Pathology University of

More information

Database of Abstracts of Reviews of Effects (DARE) Produced by the Centre for Reviews and Dissemination Copyright 2017 University of York.

Database of Abstracts of Reviews of Effects (DARE) Produced by the Centre for Reviews and Dissemination Copyright 2017 University of York. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling Brown

More information

The effectiveness of telephone reminders and SMS messages on compliance with colorectal cancer screening: an open-label, randomized controlled trial

The effectiveness of telephone reminders and SMS messages on compliance with colorectal cancer screening: an open-label, randomized controlled trial Page1 of 5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 The effectiveness of telephone reminders and SMS messages on compliance with colorectal cancer screening: an

More information

Applicable or non-applicable: investigations of clinical heterogeneity in systematic reviews

Applicable or non-applicable: investigations of clinical heterogeneity in systematic reviews Chess and Gagnier BMC Medical Research Methodology (2016) 16:19 DOI 10.1186/s12874-016-0121-7 RESEARCH ARTICLE Applicable or non-applicable: investigations of clinical heterogeneity in systematic reviews

More information

Title: What is the role of pre-operative PET/PET-CT in the management of patients with

Title: What is the role of pre-operative PET/PET-CT in the management of patients with Title: What is the role of pre-operative PET/PET-CT in the management of patients with potentially resectable colorectal cancer liver metastasis? Pablo E. Serrano, Julian F. Daza, Natalie M. Solis June

More information

Research Synthesis and meta-analysis: themes. Graham A. Colditz, MD, DrPH Method Tuuli, MD, MPH

Research Synthesis and meta-analysis: themes. Graham A. Colditz, MD, DrPH Method Tuuli, MD, MPH Research Synthesis and meta-analysis: themes Graham A. Colditz, MD, DrPH Method Tuuli, MD, MPH Today Course format Goals, competencies Overview of themes for the class SRMA M19-551 Course Format Lectures»

More information

Oral Potentially Malignant Disorders among Dental Patients

Oral Potentially Malignant Disorders among Dental Patients https://helda.helsinki.fi Oral Potentially Malignant Disorders among Dental Patients Hassona, Y. 2014 Hassona, Y, Scully, C, Almangush, A, Baqain, Z & Sawair, F 2014, ' Oral Potentially Malignant Disorders

More information

Outcomes assessed in the review

Outcomes assessed in the review The effectiveness of mechanical compression devices in attaining hemostasis after removal of a femoral sheath following femoral artery cannulation for cardiac interventional procedures Jones T Authors'

More information

الطلاوة = Leukoplakia LEUKOPLAKIA

الطلاوة = Leukoplakia LEUKOPLAKIA LEUKOPLAKIA Leukoplakia is a clinical term that refers to a predominantly white lesion of the oral mucosa that cannot be rubbed off or characterized by any other definable lesion or known disease. 130

More information

Morsicatio Mucosae Oris A Chronic Oral Frictional Keratosis, Not a Leukoplakia

Morsicatio Mucosae Oris A Chronic Oral Frictional Keratosis, Not a Leukoplakia J Oral Maxillofac Surg 67:140-146, 2009 Morsicatio Mucosae Oris A Chronic Oral Frictional Keratosis, Not a Leukoplakia Sook-Bin Woo, DMD,* and Dorothy Lin Purpose: Morsicatio mucosae oris (MMO) presents

More information

MARY F. MCCANN, LORNA M.D. MACPHERSON AND JOHN GIBSON

MARY F. MCCANN, LORNA M.D. MACPHERSON AND JOHN GIBSON The Role of the General Dental Practitioner in Detection and Prevention of Oral Cancer: A Review of the Literature MARY F. MCCANN, LORNA M.D. MACPHERSON AND JOHN GIBSON Abstract: Over the last two decades

More information

Early detection and treatment for Esophageal Cancer in Africa

Early detection and treatment for Esophageal Cancer in Africa Early detection and treatment for Esophageal Cancer in Africa Dr Michael Mwachiro Tenwek Hospital NCI-IARC ESCC Tumor Workshop Where is Tenwek Hospital? Tenwek Nairobi Tenwek Hospital Identification of

More information

Oral leukoplakia Diagnosis and treatment Kjærgaard Larsen, Marie; Sørensen, Jens Ahm; Godballe, Christian; Thygesen, Torben

Oral leukoplakia Diagnosis and treatment Kjærgaard Larsen, Marie; Sørensen, Jens Ahm; Godballe, Christian; Thygesen, Torben Syddansk Universitet Oral leukoplakia Diagnosis and treatment Kjærgaard Larsen, Marie; Sørensen, Jens Ahm; Godballe, Christian; Thygesen, Torben Published in: Journal of Oral Health and Oral Epidemiology

More information

TITLE: Immediate Osseointegrated Implants for Cancer Patients: A Review of Clinical and Cost-Effectiveness

TITLE: Immediate Osseointegrated Implants for Cancer Patients: A Review of Clinical and Cost-Effectiveness TITLE: Immediate Osseointegrated Implants for Cancer Patients: A Review of Clinical and Cost-Effectiveness DATE: 13 January 2015 CONTEXT AND POLICY ISSUES According to the World health Organization, the

More information

Oral Surgeons and the VELscope System: Partners in Early Detection & Diagnosis

Oral Surgeons and the VELscope System: Partners in Early Detection & Diagnosis David Morgan, PhD Chief Science Officer LED Dental Inc. There is a growing trend within general dentistry stressing the importance of total oral health that is, not only health of the teeth and gums but

More information

Appendix 1: Medline Search Strategy

Appendix 1: Medline Search Strategy Appendix 1: Medline Search Strategy 1. exp Parkinson Disease/ 2. exp Incidence/ 3. exp Prevalence/ 4. exp Epidemiology/ 5. 2 or 3 or 4 6. 1 and 5 7. *Parkinson Disease/ep [Epidemiology] 8. 6 or 7 9. 8

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Wu HY, Peng YS, Chiang CK, et al. Diagnostic performance of random urine samples using albumin concentration vs ratio of albumin to creatinine for microalbuminuria screening

More information

Choice of axis, tests for funnel plot asymmetry, and methods to adjust for publication bias

Choice of axis, tests for funnel plot asymmetry, and methods to adjust for publication bias Technical appendix Choice of axis, tests for funnel plot asymmetry, and methods to adjust for publication bias Choice of axis in funnel plots Funnel plots were first used in educational research and psychology,

More information

PROSPERO International prospective register of systematic reviews

PROSPERO International prospective register of systematic reviews PROSPERO International prospective register of systematic reviews The effect of probiotics on functional constipation: a systematic review of randomised controlled trials EIRINI DIMIDI, STEPHANOS CHRISTODOULIDES,

More information

Factors Influencing Smoking Behavior Among Adolescents

Factors Influencing Smoking Behavior Among Adolescents RESEARCH COMMUNICATION Factors Influencing Smoking Behavior Among Adolescents Urmi Sen 1, Arindam Basu 2 Abstract Objective To study the impact of tobacco advertisements and other social factors on the

More information

Introduction to systematic reviews/metaanalysis

Introduction to systematic reviews/metaanalysis Introduction to systematic reviews/metaanalysis Hania Szajewska The Medical University of Warsaw Department of Paediatrics hania@ipgate.pl Do I needknowledgeon systematicreviews? Bastian H, Glasziou P,

More information

Interval Cancers in BreastScreen Aotearoa

Interval Cancers in BreastScreen Aotearoa Interval Cancers in BreastScreen Aotearoa 2008 2009 Released 2018 nsu.govt.nz Citation: National Screening Unit. 2018. Interval Cancers in BreastScreen Aotearoa 2008 2009. Wellington: Ministry of Health.

More information

Long term survival study of de-novo metastatic breast cancers with or without primary tumor resection

Long term survival study of de-novo metastatic breast cancers with or without primary tumor resection Long term survival study of de-novo metastatic breast cancers with or without primary tumor resection Dr. Michael Co Division of Breast Surgery Queen Mary Hospital The University of Hong Kong Conflicts

More information

Does Buccal Cancer Have Worse Prognosis Than Other Oral Cavity Cancers?

Does Buccal Cancer Have Worse Prognosis Than Other Oral Cavity Cancers? The Laryngoscope VC 2014 The American Laryngological, Rhinological and Otological Society, Inc. Does Buccal Cancer Have Worse Prognosis Than Other Oral Cavity Cancers? P. Ryan Camilon, BA; William A. Stokes,

More information

DIAGNOSIS OF ORAL PREMALIGNANT AND MALIGNANT LESIONS USING CYTOMORPHOMETRY

DIAGNOSIS OF ORAL PREMALIGNANT AND MALIGNANT LESIONS USING CYTOMORPHOMETRY DIAGNOSIS OF ORAL PREMALIGNANT AND MALIGNANT LESIONS USING CYTOMORPHOMETRY T. RAMAESH 1, B.R.R.N. MENDIS 2, N. RATNATUNGA 3, R.O. THATTIL 4 INTRODUCTION Oral cancer is a major health problem in South East

More information

A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study

A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study ORIGINAL ARTICLE A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study Joon-Hyop Lee, MD, Yoo Seung Chung, MD, PhD,* Young Don Lee, MD, PhD

More information

18/11/2013. An Introduction to Meta-analysis. In this session: What is meta-analysis? Some Background Clinical Trials. What questions are addressed?

18/11/2013. An Introduction to Meta-analysis. In this session: What is meta-analysis? Some Background Clinical Trials. What questions are addressed? In this session: What is meta-analysis? An Introduction to Meta-analysis Geoff Der Unit Statistician MRC/CSO Social and Public Health Sciences Unit, University of Glasgow When is it appropriate to use?

More information

Original Article. IJMDS January 2018; 7(1) 1632

Original Article. IJMDS   January 2018; 7(1) 1632 A study on concordance of pre and post-surgical biopsy in oral carcinoma Sebastian J 1, Satheesan B 2, Emmnuel SP 3, Sandeepa NC 4, Asif SM 5, Kaleem SM 6, Barthunia B 7 Original Article 1 Dr Jeena Sebastian

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Tsai WC, Wu HY, Peng YS, et al. Association of intensive blood pressure control and kidney disease progression in nondiabetic patients with chronic kidney disease: a systematic

More information

Cardiovascular Disease and Commercial Motor Vehicle Driver Safety. Physical Qualifications Division April 10, 2007

Cardiovascular Disease and Commercial Motor Vehicle Driver Safety. Physical Qualifications Division April 10, 2007 Federal Motor Carrier Safety Administration Executive Summary Cardiovascular Disease and Commercial Motor Vehicle Driver Safety Presented to Physical Qualifications Division April 10, 2007 Prepared by:

More information

Data visualisation: funnel plots and maps for small-area cancer survival

Data visualisation: funnel plots and maps for small-area cancer survival Cancer Outcomes Conference 2013 Brighton, 12 June 2013 Data visualisation: funnel plots and maps for small-area cancer survival Manuela Quaresma Improving health worldwide www.lshtm.ac.uk Background Describing

More information

Oral leukoplakia, the ongoing discussion on definition and terminology

Oral leukoplakia, the ongoing discussion on definition and terminology Journal section: Oral Medicine and Pathology Publication Types: Review doi:10.4317/medoral.21007 http://dx.doi.org/doi:10.4317/medoral.21007, the ongoing discussion on definition and terminology Isaäc

More information

Leukoplakia is a clinical diagnosis 1 that may represent histologic

Leukoplakia is a clinical diagnosis 1 that may represent histologic 629 Topical Bleomycin for the Treatment of Dysplastic Oral Leukoplakia Joel B. Epstein, D.M.D., M.S.D. 1 Meir Gorsky, D.M.D. 2 Frances L. W. Wong, M.D. Amelia Millner, M.D. 1 British Columbia Cancer Agency,

More information

SYSTEMATIC REVIEW: AN APPROACH FOR TRANSPARENT RESEARCH SYNTHESIS

SYSTEMATIC REVIEW: AN APPROACH FOR TRANSPARENT RESEARCH SYNTHESIS SYSTEMATIC REVIEW: AN APPROACH FOR TRANSPARENT RESEARCH SYNTHESIS A Case Study By Anil Khedkar, India (Masters in Pharmaceutical Science, PhD in Clinical Research Student of Texila American University)

More information

OVERALL HEALTH EFFECTS OF SWEDISH MATCH SNUS PRODUCTS

OVERALL HEALTH EFFECTS OF SWEDISH MATCH SNUS PRODUCTS OVERALL HEALTH EFFECTS OF SWEDISH MATCH SNUS PRODUCTS Lester Jao Lacorte, MD, CCRP Medical Officer Office of Science Center for Tobacco Products U.S. Food and Drug Administration DISCLAIMER 1 The information

More information

Recent developments for combining evidence within evidence streams: bias-adjusted meta-analysis

Recent developments for combining evidence within evidence streams: bias-adjusted meta-analysis EFSA/EBTC Colloquium, 25 October 2017 Recent developments for combining evidence within evidence streams: bias-adjusted meta-analysis Julian Higgins University of Bristol 1 Introduction to concepts Standard

More information

How should we manage oral leukoplakia?

How should we manage oral leukoplakia? Available online at www.sciencedirect.com British Journal of Oral and Maxillofacial Surgery 51 (2013) 377 383 Review How should we manage oral leukoplakia? Anand Kumar a,, Luke Cascarini a, James A. McCaul

More information

Loss of Heterozygosity (LOH) Profiles Validated Risk Predictors for Progression to Oral Cancer

Loss of Heterozygosity (LOH) Profiles Validated Risk Predictors for Progression to Oral Cancer Research Article See Perspectives on p. 1073 and p. 1075 Cancer Prevention Research Loss of Heterozygosity (LOH) Profiles Validated Risk Predictors for Progression to Oral Cancer Lewei Zhang 4,5, Catherine

More information

Meta Analysis. David R Urbach MD MSc Outcomes Research Course December 4, 2014

Meta Analysis. David R Urbach MD MSc Outcomes Research Course December 4, 2014 Meta Analysis David R Urbach MD MSc Outcomes Research Course December 4, 2014 Overview Definitions Identifying studies Appraising studies Quantitative synthesis Presentation of results Examining heterogeneity

More information

Lara Kujtan, MD; Abdulraheem Qasem, MD

Lara Kujtan, MD; Abdulraheem Qasem, MD The Treatment of Lung Cancer Between 2013-2014 at Truman Medical Center: A Retrospective Review in Fulfillment of the Requirements of Standard 4.6 (Monitoring Compliance with Evidence- Based Guidelines)

More information

Review Article- Leukoplakia: A mysterious white patch.

Review Article- Leukoplakia: A mysterious white patch. International Journal Of Scientific Research And Education Volume 2 Issue 9 Pages 1824-1830 September-2014 ISSN (e): 2321-7545 Website: http://ijsae.in Review Article- Leukoplakia: A mysterious white patch.

More information

removal of adenomatous polyps detects important effectively as follow-up colonoscopy after both constitute a low-risk Patients with 1 or 2

removal of adenomatous polyps detects important effectively as follow-up colonoscopy after both constitute a low-risk Patients with 1 or 2 Supplementary Table 1. Study Characteristics Author, yr Design Winawer et al., 6 1993 National Polyp Study Jorgensen et al., 9 1995 Funen Adenoma Follow-up Study USA Multi-center, RCT for timing of surveillance

More information

Leukoplakia is a white patch on the oral mucous membrane, which is undeliable and can not diagnose neither clinically nor pathologically as an other

Leukoplakia is a white patch on the oral mucous membrane, which is undeliable and can not diagnose neither clinically nor pathologically as an other Leukoplakia Leukoplakia is a white patch on the oral mucous membrane, which is undeliable and can not diagnose neither clinically nor pathologically as an other disease. (Pindborg. 1978) Precancerous lesion

More information

Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable:

Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable: The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

Reproducibility of grading systems in oral epithelial dysplasia

Reproducibility of grading systems in oral epithelial dysplasia Med Oral Patol Oral Cir Bucal. 2011 Nov 1;17 (6):e935-42. Journal section: Oral Medicine and Pathology Publication Types: Research doi:10.4317/medoral.17749 http://dx.doi.org/doi:10.4317/medoral.17749

More information